Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2018-08-29 2018-08-29
Drug Identification Number 02241676 02241676
Brand name POTASSIUM CHLORIDE INJECTION POTASSIUM CHLORIDE INJECTION
Common or Proper name Potassium Chloride 10mmol in 100mL Potassium Chloride 10mmol in 100mL
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients POTASSIUM CHLORIDE POTASSIUM CHLORIDE
Strength(s) 7.46MG 7.46MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100mL 100mL
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-08-13 2018-08-13
Actual start date 2018-08-13 2018-08-13
Estimated end date 2018-08-28 2018-08-28
Actual end date 2018-08-28 2018-08-28
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Alternative doses of high-concentration potassium chloride are available. Please consult your hospital pharmacy for acceptable clinical alternatives. E.g. 10mmol KCl in 50mL SWI (JB0821P) and 20mmol KCl in 100mL SWI (JB0827P). Alternative doses of high-concentration potassium chloride are available. Please consult your hospital pharmacy for acceptable clinical alternatives. E.g. 10mmol KCl in 50mL SWI (JB0821P) and 20mmol KCl in 100mL SWI (JB0827P).
Health Canada comments